These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3940628)

  • 1. Immunotherapy of a murine lymphoma by adoptive transfer of syngeneic macrophages activated with bisantrene.
    Wang BS; Lumanglas AL; Durr FE
    Cancer Res; 1986 Feb; 46(2):503-6. PubMed ID: 3940628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    Cancer Res; 1984 Jun; 44(6):2363-7. PubMed ID: 6426780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of spleen macrophage activation in inhibiting the metastasis of transplantable tumors].
    Arkhipov SA; Iunker VM; Gruntenko EV
    Vopr Onkol; 1985; 31(9):77-84. PubMed ID: 2996226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
    Umansky V; Beckhove P; Rocha M; Krüger A; Crocker PR; Schirrmacher V
    Immunology; 1996 Feb; 87(2):303-9. PubMed ID: 8698395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
    Romani L; Fioretti MC; Bianchi R; Nardelli B; Bonmassar E
    J Natl Cancer Inst; 1982 May; 68(5):817-22. PubMed ID: 7040772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression.
    Voronov E; Weinstein Y; Benharroch D; Cagnano E; Ofir R; Dobkin M; White RM; Zoller M; Barak V; Segal S; Apte RN
    Cancer Res; 1999 Mar; 59(5):1029-35. PubMed ID: 10070959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
    Gerlier D; Avice T; Doré JF
    Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
    Aksentijevich I; Cardarelli CO; Pastan I; Gottesman MM
    Clin Cancer Res; 1996 Jun; 2(6):973-80. PubMed ID: 9816258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of cancer: experimental approach with activated macrophages proliferating in culture.
    Bartholeyns J; Lombard Y; Dumont S; Hartmann D; Chokry M; Giaimis J; Kaufmann S; Poindron P
    Cancer Detect Prev; 1988; 12(1-6):413-20. PubMed ID: 3180139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of a disseminated syngeneic mouse lymphoma by systemic adoptive transfer of immune lymphocytes and its dependence upon a host component(s).
    Mulé JJ; Rosenstein M; Shu S; Rosenberg SA
    Cancer Res; 1985 Feb; 45(2):526-31. PubMed ID: 3881168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive immunotherapy of solid tumors with activated macrophages: experimental and clinical results.
    Bartholeyns J; Lopez M; Andreesen R
    Anticancer Res; 1991; 11(3):1201-4. PubMed ID: 1888150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW
    Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of the SL2-5 murine lymphoma with natural killer cells and tamoxifen or toremifene.
    Baral E; Nagy E; Kangas L; Berczi I
    Anticancer Res; 1997; 17(1A):77-83. PubMed ID: 9066633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the involvement of cells from donor and recipient mice in adoptive transfer of antitumor immunity.
    Lee FH; Currie D; Hwang KM
    Cancer Res; 1984 Dec; 44(12 Pt 1):5491-8. PubMed ID: 6208997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of peritoneal cells on tumors cells growth in vitro.
    Salwa J
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):37-41. PubMed ID: 8744682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells.
    Suzuki T; Fukuhara T; Tanaka M; Nakamura A; Akiyama K; Sakakibara T; Koinuma D; Kikuchi T; Tazawa R; Maemondo M; Hagiwara K; Saijo Y; Nukiwa T
    Clin Cancer Res; 2005 Jan; 11(1):58-66. PubMed ID: 15671528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.
    Han X; Wilbanks GD; Devaja O; Ruperelia V; Raju KS
    Gynecol Oncol; 1999 Nov; 75(2):198-210. PubMed ID: 10525372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.